Australian Clinical Labs Ltd (ACL) — Cash Flow Quality Index
Australian Clinical Labs Ltd (ACL) has a Cash Flow Quality Index of 11.29x as of December 2025. Operating cash flow of AU$62.87 Million exceeds net income of AU$5.57 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Australian Clinical Labs Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Australian Clinical Labs Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Australian Clinical Labs Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Australian Clinical Labs Ltd (ACL) cash flow conversion.
Annual Cash Flow Quality Index for Australian Clinical Labs Ltd (2019–2025)
Year-by-year earnings quality comparison for Australian Clinical Labs Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▲ +0.0% |
| 2024 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▼ -15.5% |
| 2024 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +0.0% |
| 2023 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +66.6% |
| 2023 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +0.0% |
| 2022 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +151.1% |
| 2022 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▲ +0.0% |
| 2021 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▼ -37.5% |
| 2021 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +0.0% |
| 2020 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +3.3% |
| 2020 | 2.47x | AU$101.74 Million | AU$41.26 Million | ▲ +0.0% |
| 2019 | 2.47x | AU$101.74 Million | AU$41.26 Million | — |